Pediatric cancer survivors at risk for opioid misuseMay 5, 2021ALLPatient & Survivor CareOpioid Resource CenterPediatricsAMLB Cell LymphomaCLL
Omidubicel improves on umbilical cord blood transplantsMarch 22, 2021TransplantALLAMLCMLMyelodysplastic SyndromeB Cell Lymphoma
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareAggressive LymphomasB Cell LymphomaT Cell LymphomasMultiple MyelomaMantle Cell LymphomaIndolent Lymphoma
Maribavir seen as superior to other antivirals for CMV clearance post transplantMarch 4, 2021TransplantAML
Using engineered T cells reduced acute, chronic GVHDFebruary 23, 2021TransplantALLAMLB Cell LymphomaMyelodysplastic SyndromeCellular Therapy
Chronic GVHD therapies offer hope for treating refractory diseaseFebruary 17, 2021TransplantMyelodysplastic SyndromeMultiple MyelomaALLAMLDLBCLB Cell Lymphoma
Prevention of HMA failure a goal for high-risk MDS posttransplantNovember 13, 2020TransplantAMLMyelodysplastic Syndrome
Are HMAS appropriate for posttransplant maintenance in acute leukemias?November 5, 2020ALLTransplantAMLMyelodysplastic Syndrome
